SVB’s Future of Cleantech report reveals $7.6B invested in cleantech (15% YoY growth), $20B VC funding in U.S. climate tech, and 75% of 2024 deals in Seed/Series A—signaling strong early-stage momentum. Read more: tinyurl.com/yvc92wz8 #cleantech #climatesolutions

#KeiretsuBacked Joule Case partners with DonutNV to power silent, eco-friendly food trucks. Their battery system runs 10+ hrs on a single charge—no fumes, no noise. A game-changer for franchisees and guests alike. Learn more: tinyurl.com/3pjehajj #ecofriendly #cleantech

PredxBio partners with Hamamatsu Photonics to advance cancer immuno-oncology. Combining MoxiePlex & SpaceIQ, researchers can now gain faster insights into immune cell behavior, pathways, and biomarker grouping. Learn more: tinyurl.com/ya6nf4e5 #cancerresearch #medtech

GlobalData reports the US VC funding share jumped from 43% in Q1 2024 to 58% in Q1 2025, with ~30% of global VC deals. This surge cements the US as the world’s most active VC market and a key hub for innovation. #usa #venturecapital #innovation

#KeiretsuBacked b.well Connected Health wins “Best Healthcare Big Data Solution” at the 9th MedTech Breakthrough Awards—for the second year in a row! A proud moment that highlights the power of their AI-driven Large Health Model.

A polished pitch opens doors, but it won’t close the deal. Investors want proof, not just promises. Traction, metrics, and solid fundamentals matter more than showmanship. Let’s bust the myth: a great pitch alone won’t get you funded.

2024 was one of the most active years for venture capital in terms of deal value. Investors put in a whopping $180 billion to support early-stage companies, most of them focused on AI. It is a 27% increase from 2023, and marks 2024 as the third-highest year for VC deployment.

Rejected by a VC? It’s not the end. Rejection is a lesson—refine, adapt, and rework your pitch. Keep building your vision. The right ‘yes’ is still out there.

#KeiretsuBacked FEMSelect has closed an oversubscribed Series B round, led by New Age Ventures & Triventures. Backed by strong investor confidence, the raise will support leadership growth, U.S. HQ relocation & broader commercialization. Big steps ahead!

#KeiretsuBacked FEMSelect closed an oversubscribed Series B round led by New Age Ventures & Triventures. This vote of confidence powers their next chapter: leadership growth, U.S. HQ move & expanded commercialization. Read more: tinyurl.com/mrum6f74

#KeiretsuBacked PredxBio just launched an enhanced SpaceIQ™—a powerful platform that gives researchers a high-res view of how tumors behave and respond to treatment. A leap forward for precision immuno-oncology. Read more: tinyurl.com/wzuujymc

#KeiretsuBacked LumiThera shared promising results for Valeda—its FDA-approved, non-invasive light therapy for dry AMD. Valeda stimulates retinal cells to improve vision, with benefits lasting up to 4.5 years. Read more: tinyurl.com/yc22j4er

#KeiretsuBacked UbiQD® has raised $20M in Series B funding led by Phoenix Venture Partners, with support from Builders VC, Azura Group & more—boosting their quantum dot tech that's redefining agri, solar & security through smarter, sustainable light solutions.

#KeiretsuBacked Pattern Computer® has submitted a liver cancer study for peer review. Their model, using the Pattern Discovery Engine™, hit 97% accuracy in identifying cancer cells and revealed gene activity patterns that could improve diagnosis and understanding.

\#KeiretsuBacked Archax expands into the UAE with a new tech hub at Dubai’s DIFC under an Innovation License — marking its first regional presence and a key step in tapping into the Middle East’s growing digital asset ecosystem.

#KeiretsuBacked Hotel Communication Network (HCN) acquires UK-based Crave Interactive to expand its AI-driven guest engagement tech across more luxury hotels globally — strengthening its foothold in the high-end hospitality market.

#KeiretsuBacked Vispera’s AI retail solution, Shelfsight, earns the EU’s prestigious Seal of Excellence under Horizon Europe 2024 — recognizing its breakthrough innovation and market potential in intelligent retail. Read more: tinyurl.com/3uc2drdv

#KeiretsuBacked NuvOx doses first patient in EXTEND trials for NanO2, a novel oxygen therapeutic targeting ARDS and mild respiratory distress. Early studies show promise in boosting oxygen, reducing inflammation & improving survival. Read more: tinyurl.com/bdks3yhc

#KeiretsuBacked PredxBio, with Dr. Arutha Kulasinghe & Queensland Spatial Biology Centre, uses SpaceIQ™ to cut biomarker panels from 40–70 to just 1–2 markers—without losing accuracy—paving the way for faster, effective cancer diagnostics. Read More: tinyurl.com/ywtctpnv

#KeiretsuBacked Spinal Simplicity launches Patriot-SI™, the first fully cannulated SI joint fusion implant. 3D-printed titanium & fully coated for better bone bonding—designed for consistent surgeries, faster healing & precise placement. Read More: tinyurl.com/3nbrexn2